Stock BBLG BONE BIOLOGICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bone Biologics Corporation

Equities

BBLG

US0980705018

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-29 pm EDT 		5-day change 1st Jan Change
1.55 USD -2.52% Intraday chart for Bone Biologics Corporation +1.97% -65.71%
May. 04 Certain Common Stock of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024. CI
May. 04 Certain Warrants of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024. CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 230.1 36.43 3.209 2.414 1.398 - -
Enterprise Value (EV) 1 230.1 36.43 3.209 2.414 1.398 1.398 1.398
P/E ratio -30 x -10.1 x -1.61 x -0.13 x -0.29 x -0.32 x -0.32 x
Yield - - - - - - -
Capitalization / Revenue - - - - - - -
EV / Revenue - - - - - - -
EV / EBITDA - - - - - - -
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 51.1 43.1 63.8 534 879.2 - -
Reference price 2 4,500 844.8 50.33 4.520 1.550 1.550 1.550
Announcement Date 4/15/21 3/15/22 3/30/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - - - -
EBITDA - - - - - - -
EBIT - - -3.665 - - -4.062 -4.286
Operating Margin - - - - - - -
Earnings before Tax (EBT) - - -1.485 - - -3.886 -4.108
Net income -1.825 -1.611 -1.485 -8.949 - -3.886 -4.108
Net margin - - - - - - -
EPS 2 -150.0 -84.00 -31.20 -34.01 -5.320 -4.840 -4.870
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 4/15/21 3/15/22 3/30/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - - - - - - - - - - - - - -
EBITDA - - - - - - - - - - - - - -
EBIT 1 - - - -1.219 - - - -2.081 - -1.003 -1.015 -1.029 - -
Operating Margin - - - - - - - - - - - - - -
Earnings before Tax (EBT) 1 - - - -1.219 - - - -1.92 - -0.9629 -0.9738 -0.9851 - -
Net income 1 - - - -1.219 - - - -1.92 - -0.9629 -0.9738 -0.9851 - -
Net margin - - - - - - - - - - - - - -
EPS 2 -12.00 -16.80 - -28.80 24.00 -55.20 -13.52 -4.880 -1.310 -1.390 -1.340 -1.290 -1.250 -1.200
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 3/15/22 5/13/22 8/11/22 11/14/22 3/30/23 5/15/23 8/14/23 11/14/23 5/14/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 4/15/21 3/15/22 3/30/23 2/21/24 - - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
BONE BIOLOGICS CORPORATION Stock Bone Biologics Corporation
-65.71% 1.4M
STRYKER CORPORATION Stock Stryker Corporation
+13.92% 129B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.11% 10.92B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-3.68% 8.5B
GLAUKOS CORPORATION Stock Glaukos Corporation
+38.81% 5.5B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-21.15% 4.69B
AXONICS, INC. Stock Axonics, Inc.
+7.67% 3.42B
ENOVIS CORPORATION Stock Enovis Corporation
-11.71% 2.73B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-9.90% 2B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-13.94% 1.93B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. BBLG Stock
  4. Financials Bone Biologics Corporation